Page last updated: 2024-10-24

busulfan and Cell Transformation, Neoplastic

busulfan has been researched along with Cell Transformation, Neoplastic in 25 studies

Cell Transformation, Neoplastic: Cell changes manifested by escape from control mechanisms, increased growth potential, alterations in the cell surface, karyotypic abnormalities, morphological and biochemical deviations from the norm, and other attributes conferring the ability to invade, metastasize, and kill.

Research Excerpts

ExcerptRelevanceReference
"In polycythemia vera (PV), treatment with chlorambucil and radioactive phosphorus (p32) increases the risk of leukemic transformation from 1% to 13-14%."7.69Leukemogenic risk of hydroxyurea therapy in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis. ( Fisher, SG; Godwin, J; Nand, S; Stock, W, 1996)
"In polycythemia vera (PV), treatment with chlorambucil and radioactive phosphorus (p32) increases the risk of leukemic transformation from 1% to 13-14%."3.69Leukemogenic risk of hydroxyurea therapy in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis. ( Fisher, SG; Godwin, J; Nand, S; Stock, W, 1996)
" Two patients had been treated with uracil mustard: One developed acute myelogenous leukemia 79 months after institution of therapy, and the other patient developed chronic myelomonocytic leukemia 24 months after the start of therapy."3.67Essential thrombocythemia and leukemic transformation. ( Curtis, JL; Levin, J; Sedlacek, SM; Weintraub, J, 1986)
"Hypercalcemia is a serious complication of malignancies, but it is uncommon in acute leukemia."1.31Megakaryoblastic transformation of polycythemia vera with hypercalcemia. ( Iwasaki, H; Kurosawa, M, 2002)
"The patient who had trisomy 8 at the time of diagnosis underwent myeloid blastic transformation in 35 months."1.31Leukemic transformation with trisomy 8 in essential thrombocythemia: a report of four cases. ( Hirose, Y; Masaki, Y; Sugai, S, 2002)
"Three cases of chronic myelogenous leukemia (CML) were studied, occurring in 22, 43, and 30-year-old-men."1.26["Lymphoid" blastic transformation in chronic myelogenous leukemia. Report of three cases (author's transl)]. ( Bauters, F; Goudemand, M; Huart, JJ; Jouet, JP; Jude, B; Toussaint, B, 1982)

Research

Studies (25)

TimeframeStudies, this research(%)All Research%
pre-199021 (84.00)18.7374
1990's1 (4.00)18.2507
2000's3 (12.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kurosawa, M1
Iwasaki, H1
Nix, WL1
Fernbach, DJ1
Bauters, F1
Jouet, JP1
Huart, JJ1
Jude, B1
Toussaint, B1
Goudemand, M1
Preisler, HD1
Kirshner, J1
Woodruff, RK1
Nand, S1
Stock, W1
Godwin, J1
Fisher, SG1
Bolwell, B1
Kalaycio, M1
Andresen, S1
Goormastic, M1
McBee, M1
Kuczkowski, E1
Wise, K1
Sobecks, R1
Pohlman, B1
Hirose, Y1
Masaki, Y1
Sugai, S1
Abe, T1
Spiers, AS2
Canellos, GP2
Nasrallah, AG1
McGarry, MP1
van Putten, LM1
Kram, LK1
van Dierendonck, HH1
Smink, T1
Füzy, M1
Champlin, RE1
Golde, DW1
Knottenbelt, E1
Hallett, J1
Jacobs, P1
Sedlacek, SM1
Curtis, JL1
Weintraub, J1
Levin, J1
Lingg, G1
Schmalzl, F1
Breton-Gorius, J1
Tabilio, A1
Schaefer, HE1
Geissler, D1
Schweiger, M1
Kirchmair, W1
Aust, C1
Boll, I1
Mason, JE1
DeVita, VT1
Garson, OM1
de Gruchy, GC1
Stryckmans, PA1
Visfeldt, J1
Franzén, S1
Nielsen, A1
Tribukait, B1
Gibson, OM1
Burgess, MA1
Stanley, LG1
De Grouchy, J1
De Nava, C1
Feingold, J1
Bilski-Pasquier, G1
Bousser, J1

Reviews

7 reviews available for busulfan and Cell Transformation, Neoplastic

ArticleYear
Myeloproliferative diseases in childhood.
    The American journal of pediatric hematology/oncology, 1981,Winter, Volume: 3, Issue:4

    Topics: Adolescent; Adrenal Cortex Hormones; Busulfan; Cell Transformation, Neoplastic; Child; Child, Presch

1981
Chronic myeloid leukaemia.
    Australian and New Zealand journal of medicine, 1981, Volume: 11, Issue:6

    Topics: Acute Disease; Adult; Bone Marrow Transplantation; Busulfan; Cell Transformation, Neoplastic; Child,

1981
[Myelocytic leukemia: cytogenetic consideration].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 1975, Volume: 16, Issue:9

    Topics: Acute Disease; Aneuploidy; Bone Marrow; Bone Marrow Cells; Busulfan; Cell Transformation, Neoplastic

1975
The treatment of chronic granulocytic leukaemia.
    Clinics in haematology, 1977, Volume: 6, Issue:1

    Topics: BCG Vaccine; Busulfan; Cell Transformation, Neoplastic; Chromosomes, Human, 21-22 and Y; Humans; Leu

1977
The treatment of chronic granulocytic leukaemia.
    British journal of haematology, 1976, Volume: 32, Issue:3

    Topics: Adult; Blood Transfusion; Busulfan; Cell Transformation, Neoplastic; Chronic Disease; Humans; Immuno

1976
Chronic myelogenous leukemia: recent advances.
    Blood, 1985, Volume: 65, Issue:5

    Topics: Bone Marrow Transplantation; Busulfan; Cell Transformation, Neoplastic; Chromosomes, Human, 21-22 an

1985
Current concepts in chronic myelogenous leukemia.
    Seminars in hematology, 1974, Volume: 11, Issue:2

    Topics: Alkaline Phosphatase; Blood; Bone Marrow Cells; Bone Marrow Examination; Busulfan; Cell Division; Ce

1974

Other Studies

18 other studies available for busulfan and Cell Transformation, Neoplastic

ArticleYear
Megakaryoblastic transformation of polycythemia vera with hypercalcemia.
    Annals of hematology, 2002, Volume: 81, Issue:11

    Topics: Adrenocorticotropic Hormone; Bone Resorption; Busulfan; Calcium; Cell Transformation, Neoplastic; Di

2002
["Lymphoid" blastic transformation in chronic myelogenous leukemia. Report of three cases (author's transl)].
    La semaine des hopitaux : organe fonde par l'Association d'enseignement medical des hopitaux de Paris, 1982, Jan-07, Volume: 58, Issue:1

    Topics: Adult; Busulfan; Cell Transformation, Neoplastic; Drug Therapy, Combination; Humans; Leukemia, Lymph

1982
In vitro drug sensitivity studies of CFUc in chronic myelocytic leukemia: I. Suicide indices and busulfan sensitivity determinations during the chronic phase.
    Experimental hematology, 1983, Volume: 11, Issue:7

    Topics: Adolescent; Adult; Aged; Blood Cells; Bone Marrow; Busulfan; Cell Transformation, Neoplastic; Clone

1983
Leukemogenic risk of hydroxyurea therapy in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis.
    American journal of hematology, 1996, Volume: 52, Issue:1

    Topics: Acute Disease; Anemia, Refractory, with Excess of Blasts; Busulfan; Cell Transformation, Neoplastic;

1996
Autologous peripheral blood progenitor cell transplantation for transformed diffuse large-cell lymphoma.
    Clinical lymphoma, 2000, Volume: 1, Issue:3

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Cell Transformati

2000
Leukemic transformation with trisomy 8 in essential thrombocythemia: a report of four cases.
    European journal of haematology, 2002, Volume: 68, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Bone Marrow; Busulfan; Cell Transformation, Neoplastic; Chromosomes,

2002
The clinical features of chronic granulocytic leukaemia.
    Clinics in haematology, 1977, Volume: 6, Issue:1

    Topics: Adult; Busulfan; Cell Transformation, Neoplastic; Female; Humans; Leukemia, Myeloid; Male; Middle Ag

1977
In vivo distinction between a target cell for Friend virus (FVP) and murine hematopoietic stem cells.
    Journal of the National Cancer Institute, 1976, Volume: 57, Issue:2

    Topics: Animals; Busulfan; Cell Transformation, Neoplastic; Erythrocytes; Erythropoietin; Female; Friend mur

1976
Enhancement by drugs of metastatic lung nodule formation after intravenous tumour cell injection.
    International journal of cancer, 1975, Apr-15, Volume: 15, Issue:4

    Topics: Alkylating Agents; Animals; Antineoplastic Agents; Busulfan; Cell Transformation, Neoplastic; Globul

1975
8;21 translocation in myelodysplasia secondary to essential thrombocythemia.
    American journal of hematology, 1989, Volume: 30, Issue:4

    Topics: Aged; Busulfan; Cell Transformation, Neoplastic; Cytogenetics; Female; Humans; Karyotyping; Leukemia

1989
Essential thrombocythemia and leukemic transformation.
    Medicine, 1986, Volume: 65, Issue:6

    Topics: Adult; Aged; Bone Marrow; Busulfan; Cell Transformation, Neoplastic; Humans; Leukemia, Myeloid; Leuk

1986
Megakaryoblastic micromegakaryocytic crisis in chronic myeloid leukemia.
    Blut, 1985, Volume: 51, Issue:4

    Topics: Bone Marrow Cells; Busulfan; Cell Transformation, Neoplastic; Female; Humans; Karyotyping; Leukemia,

1985
[Development of Di-Gugliemo syndromes from chronic myelocytic leukemias].
    Blut, 1974, Volume: 28, Issue:4

    Topics: Adult; Aged; Bone Marrow Cells; Bone Marrow Examination; Busulfan; Cell Transformation, Neoplastic;

1974
Thrombocytosis in chronic granulocytic leukemia: incidence and clinical significance.
    Blood, 1974, Volume: 44, Issue:4

    Topics: Anemia; Azauridine; Blood Cell Count; Blood Platelets; Bone Marrow Examination; Busulfan; Cell Trans

1974
Chromosome changes in the blastic transformation stage of chronic granulocytic leukaemia.
    Haematologia, 1974, Volume: 8, Issue:1-4

    Topics: Bone Marrow Cells; Busulfan; Cell Transformation, Neoplastic; Chromosome Aberrations; Chromosomes, H

1974
Primary polycythaemia. 3. Studies on the significance of the history of the disease and of the treatment for the development of clones in bone marrow cells.
    Acta pathologica et microbiologica Scandinavica. Section A, Pathology, 1973, Volume: 81, Issue:2

    Topics: Adult; Aged; Bone Marrow; Bone Marrow Cells; Busulfan; Cell Transformation, Neoplastic; Clone Cells;

1973
Cytogenetic remission in acute transformation of chronic granulocytic leukaemia.
    British medical journal, 1969, May-31, Volume: 2, Issue:5656

    Topics: Acute Disease; Aged; Aneuploidy; Bone Marrow Diseases; Busulfan; Cell Transformation, Neoplastic; Ch

1969
[Eleven observations on a precise model of karyotype changes in the course of chronic myeloid leukemia].
    European journal of cancer, 1968, Volume: 4, Issue:5

    Topics: Adult; Aged; Busulfan; Cell Transformation, Neoplastic; Chromosome Aberrations; Clone Cells; Female;

1968